| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |